← All Rallybio CORP filings

Rallybio CORP Form 4 insider transactions

NASDAQ
RLYB
Rallybio CORP
Form 4: Rallybio Corp Director Ronald Hunt Acquires Options
Director Ronald Hunt acquired options to purchase 16,500 shares of Rallybio Corp common stock on May 15, 2024.
NASDAQ
RLYB
Rallybio CORP
Form 4: Rallybio Corp Director Helen M Boudreau Acquires Options
Director Helen M Boudreau acquired options to purchase 16,500 shares of Rallybio Corp common stock on May 15, 2024.
NASDAQ
RLYB
Rallybio CORP
Form 4: Rallybio Corp Director Liu Hui Acquires Options
Director Liu Hui acquired options to purchase 16,500 shares of Rallybio Corp stock on May 15, 2024.
NASDAQ
RLYB
Rallybio CORP
Form 4: Rallybio Corp Director Kush Parmar Acquires Options
Director Kush Parmar acquired options to purchase 16,500 shares of Rallybio Corp common stock at an exercise price of $1.91 on May 15, 2024.
NASDAQ
RLYB
Rallybio CORP
Form 4: Rallybio Corp Director Paula Soteropoulos Acquires Options
Director Paula Soteropoulos acquired options to purchase 16,500 shares of Rallybio Corp common stock on May 15, 2024.
NASDAQ
RLYB
Rallybio CORP
Form 4: Rallybio Corp Director, Christine A. Nash, Acquires Options
Christine A. Nash, a director of Rallybio Corp, reports the acquisition of options to purchase 16,500 shares of common stock.
NASDAQ
RLYB
Rallybio CORP
Form 4: Rallybio Corp Director Hopfner Acquires Options
Director Robert Lorne Hopfner acquired options to purchase 16,500 shares of Rallybio Corp common stock on May 15, 2024.
NASDAQ
RLYB
Rallybio CORP
Form 4: Rallybio Corp Director Wendy Chung Acquires Options
Director Wendy Chung acquired options to purchase 16,500 shares of Rallybio Corp common stock on May 15, 2024.